TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

NCT00328523 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1496

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolaemia
Hyperlipidaemia

Interventions

DRUG: MK-0653, ezetimibe
DRUG: Duration of Treatment: 3 months

Sponsor

Organon and Co